GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
Follow
GreenLight Biosciences
@GreenLightBio1
A mission-driven public-benefit corporation using the power of RNA to tackle some of humanity's greatest challenges.
GreenLight Biosciences’s Tweets
Our work to protect bees from the Varroa destructor mite is mentioned in this article from of .
2
Thank you to everybody for your positive feedback on our CEO's vision for using RNA to feed the world and keep it healthy, presented at the Abu Dhabi Sustainability Week today.
1
6
Andrey Zarur, GreenLight CEO, has been sharing our vision for supporting sustainability through feeding the world and keeping it healthy at Abu Dhabi Sustainability Week today. Further details can be found at:
1
GreenLight Biosciences and EpiVax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines
4
5
Our CEO presented to investors at and conferences in November this year.
Watch his presentation here:
3
Happy to be here in Kigali and on panel headed by His Honour the Rwandan Minister of State for Health Yvan Butera, discussing how Africa can be at the forefront of biomedical research and development.
#CPHIA2022
3
8
GreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress.
3
GreenLight CEO explains how GreenLight is targeting global human health challenges in this video presentation to 's 31st Annual Healthcare Conference
2
We have come a long way since early 2021. Watch some highlights of our mission to provide an RNA platform that feeds the world and keeps it healthy.
1
3
Sad news from Central America shows that the link between public health and environmental protection is extremely close. We must find agricultural solutions that feed the world and keep us healthy.
Article: of
2
Our research partner of explains how RNA could help provide a solution to fall armyworm, which is responsible for around $3.2 billion in crop loss each year.
More about our research deal with the Queensland University of Technology here: greenlightbiosciences.com/greenlight-bio
2:03
58 views
3
This September our women's employee resource group hosted a roundtable discussion about career paths in biotech. They were joined by four successful female GreenLighters to share their stories.
1
7
GreenLight is spotlighted in this piece for our RNA solution for the Colorado potato beetle, currently under review by the EPA.
Piece by of
2
3
News: GreenLight is partnering with Queensland University of Technology to to create a solution for fall armyworm, which is responsible for more than $2 billion in annual crop loss worldwide.
6
9
Read how we're aiming to address some of the world's most difficult problems, from climate change to global health inequality in our latest investor presentation.
greenlightbiosciences.com/greenlight-aug
4
GreenLight held a basketball tournament earlier this week with four teams dueling for the championship. Congratulations to our winning team of Walter, Conan, and Andrey on securing our inaugural title!
3
Our paint evening organised by the GreenLight wellness committee was a great success. Thank you to Diana, our local painter expert, for all your help creating some masterpieces.
7
Powerful opening to #AGRF2022 by #Rwanda’s Minister of Agriculture highlighting that we are in multiple crises now, & some have brought new technologies to Africa which must be accelerated such as #RNA technology for both human & plant health 🌱 #OneHealth
5
20
GreenLight has partnered with the to develop Covid-19 vaccines that are more broadly protective and have longer-lasting effects.
2
8
Thanks to for installing GreenLight bee hives on our RTP campus.
We're happy to welcome a lively hive of bees to the GreenLight family.
1
11
“The simple fact is that we lose up to 40% of the foods that we produce to… pathogens, pests, fungi, and insects.”
GreenLight CEO on the growing problem of food insecurity in an interview with BNP Paribas.
bnpparibas-am.be/professional-i
3
6
GreenLight Biosciences Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress.
greenlightbiosciences.com/quarterly-earn
1
3
GreenLight Biosciences announces $109 million financing.
CEO said: "We are grateful for the support, conviction, and trust of our returning investors. We are also delighted to welcome new investors who have decided to join GreenLight."
greenlightbiosciences.com/greenlight-bio
1
6
12
GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine.
More details on our website here:
1
3
8
We are excited to announce a new collaboration on developing more responsive Covid-19 vaccines with the .
3
10
Today marks Earth Overshoot Day: the day in which humanity surpasses the biological resources our planet regenerates for the year.
Our RNA products aim to support agricultural practices that will reduce food waste, and help the planet.
#MoveTheDate
2
4
GreenLight CEO talks to about how RNA can be used to feed the world, by tackling food-destroying pests and fungi.
1
3
7
Our work to protect honeybees from the varroa destructor mite is featured by Bloomberg today:
bloomberg.com/news/articles/
9
7
GreenLight research to improve assay performance in collaboration with is featured in .
This work may help assess critical quality attributes of RNA products. Congratulations to the our Analytical Sciences team.
3
8
We are using the power of RNA to protect our planet's most essential crops.
Our state-of-the-art manufacturing facility in Rochester, New York will allow us to mass-produce RNA to eliminate pests such as the Colorado potato beetle.
bloomberg.com/news/articles1
2
5
Protecting agriculture, fighting against world hunger, and making vaccines accessible for all are at the forefront of our mission.
We are committed to using RNA to create affordable and sustainable solutions to solve the world's most challenging problems.
1
“Biodiversity does not wait . . . species are going into extinction.”
GreenLight welcomes EU plans to boost farmland biodiversity: we are researching more sustainable crop solutions with partners in Italy & Spain.
By and
3
The EU plans to cut use of traditional pesticides in half by 2030.
Pests reduce crop yields by ~30% globally. Our RNA solutions aim to cut traditional pesticide use without compromising on productivity.
Article: &
1
5
"Time is an issue, and there is a race against the clock."
Learn how GreenLight is researching a solution to protect bees against the parasitic varroa mite in collaboration with Hart Honey Farms in Georgia, and
4
Our work to rapidly screen genetic variants to help address crop pests was featured in last week.
Our proprietary algorithms will help us design pest solutions increasingly faster, smarter, and more efficiently.
1
4
For RNA to work in human vaccines, you have to have the “proper vehicle.”
Lorenzo Aulisa, GreenLight’s Head of messenger RNA Delivery Technology, explains how GreenLight’s RNA vaccine candidate overcomes some of the traditional barriers to RNA delivery.
3
GreenLight COO Carole Cobb explains our mission to protect honeybees and feed the world in this film in collaboration with
#AgeOfChange
1
5
5
To cap off pride, the GreenLight team in four US locations did LGBTQ+ fabric prints with stencils and their own art.
Thank you to our amazing LGBTQ+ employee resource group RainbowLight for organizing it and providing pizza. 🏳️🌈
1
4
Thanks to our collaborators in New Zealand, we now understand more about how Varroa destructor mites are impacted by our RNA solution.
Quote Tweet
Will RNAi to reduce varroa populations? Rose presenting on her work how dsRNA affects mite reproduction, from @pjlester and @GreenLightBio1 #NZhoneybeeresearch
3